Molecular Epidemiology, Sequence Types, and Plasmid Analyses of KPC-Producing Klebsiella pneumoniae Strains in Israel

Antimicrobial Agents and Chemotherapy
2010.0

Abstract

Sporadic isolates of carbapenem-resistant KPC-2-producing Klebsiella pneumoniae were isolated in Tel Aviv Medical Center during 2005 and 2006, parallel to the emergence of the KPC-3-producing K. pneumoniae sequence type 258 (ST 258). We aimed to study the molecular epidemiology of these isolates and to characterize their bla(KPC)-carrying plasmids and their origin. Ten isolates (8 KPC-2 and 2 KPC-3 producing) were studied. All isolates were extremely drug resistant. They possessed the bla(KPC) gene and varied in their additional beta-lactamase contents. The KPC-2-producing strains belonged to three different sequence types: ST 340 (n = 2), ST 277 (n = 2), and a novel sequence type, ST 376 (n = 4). Among KPC-3-producing strains, a single isolate (ST 327) different from ST 258 was identified, but both strains carried the same plasmid (pKpQIL). The KPC-2-encoding plasmids varied in size (45 to 95 kb) and differed among each of the STs. Two of the Klebsiella bla(KPC-2)-carrying plasmids were identical to plasmids from Escherichia coli, suggesting a common origin of these plasmids. These data indicate that KPC evolution in K. pneumoniae is related to rare events of interspecies spread of bla(KPC-2)-carrying plasmids from E. coli followed by limited clonal spread, whereas KPC-3 carriage in this species is related almost strictly to clonal expansion of ST 258 carrying pKpQIL.

Knowledge Graph

Similar Paper

Molecular Epidemiology, Sequence Types, and Plasmid Analyses of KPC-Producing Klebsiella pneumoniae Strains in Israel
Antimicrobial Agents and Chemotherapy 2010.0
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland
Antimicrobial Agents and Chemotherapy 2009.0
Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli Hospital
Antimicrobial Agents and Chemotherapy 2007.0
Carbapenem-Resistant KPC-2-Producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008
Antimicrobial Agents and Chemotherapy 2010.0
Emergence of Serratia marcescens , Klebsiella pneumoniae , and Escherichia coli Isolates Possessing the Plasmid-Mediated Carbapenem-Hydrolyzing β-Lactamase KPC-2 in Intensive Care Units of a Chinese Hospital
Antimicrobial Agents and Chemotherapy 2008.0
Genetic Organization of Transposase Regions Surrounding bla <sub>KPC</sub> Carbapenemase Genes on Plasmids from Klebsiella Strains Isolated in a New York City Hospital
Antimicrobial Agents and Chemotherapy 2009.0
Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from China
Antimicrobial Agents and Chemotherapy 2007.0
Emerging Klebsiella pneumoniae Isolates Coproducing KPC-2 and VIM-1 Carbapenemases
Antimicrobial Agents and Chemotherapy 2009.0
Plasmid-Mediated Carbapenem-Hydrolyzing β-Lactamase KPC-2 in Klebsiella pneumoniae Isolate from Greece
Antimicrobial Agents and Chemotherapy 2008.0
Complete Nucleotide Sequence of Klebsiella pneumoniae Multidrug Resistance Plasmid pKP048, Carrying bla <sub>KPC-2</sub> , bla <sub>DHA-1</sub> , qnrB4 , and armA
Antimicrobial Agents and Chemotherapy 2010.0